Literature DB >> 6913607

Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a.

A Nicholson-Weller, J Burge, K F Austen.   

Abstract

A protein with decay-accelerating activity for the classical C3 convertase, C4b2a, has been isolated on the basis of this function from guinea pig erythrocyte stroma. The isolation procedure for decay-accelerating factor of stroma (DAF-S) utilizes butanol extraction and chromatography on DEAE-Sephacel, hydroxylapatite, and phenyl Sepharose. Purified DAF-S has a m.w. of 60,000 and 65,000 on reduced and unreduced SDS gels, respectively, and exhibits m.w. of 30,000 and 175,000 on alkaline gradient gels, suggesting multiples of a 60,000-65,000 subunit. Purified DAF-S elicited a monospecific antiserum whose IgG fraction neutralized the decay-accelerating activity for C4b,2a affixed to 10(7) sheep erythrocytes (EAC1,4,2) in a dose-response fashion. The monospecific antiserum diluted up to 1:5120 agglutinated 1 x 10(6) guinea pig erythrocytes, but not sheep or human erythrocytes, suggesting that DAF-S, an integral membrane protein, has species-specific antigens that are expressed on the surface of the guinea pig erythrocyte.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6913607

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Kinetics of assembly and decay of complement components on Escherichia coli O111:B4 preparation of stable intermediates.

Authors:  G Rottini; F Tedesco; M Basaglia; L Roncelli; P Patriarca
Journal:  Infect Immun       Date:  1985-08       Impact factor: 3.441

Review 2.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

3.  The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).

Authors:  T M Karnauchow; D L Tolson; B A Harrison; E Altman; D M Lublin; K Dimock
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

Review 4.  Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.

Authors:  Patrick M Glassman; Elizabeth D Hood; Laura T Ferguson; Zongmin Zhao; Don L Siegel; Samir Mitragotri; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2021-09-29       Impact factor: 15.470

5.  Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.

Authors:  A Nicholson-Weller; J P March; S I Rosenfeld; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

6.  Evidence for linkage between the loci coding for the binding protein for the fourth component of human complement (C4BP) and for the C3b/C4b receptor.

Authors:  S Rodriguez de Cordoba; T R Dykman; F Ginsberg-Fellner; G Ercilla; M Aqua; J P Atkinson; P Rubinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

7.  Cell-surface bound complement regulatory activity is necessary for the in vivo survival of KDH-8 rat hepatoma.

Authors:  L Baranyi; K Baranji; H Takizawa; N Okada; H Okada
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

8.  Cytolysis of Sendai virus-infected guinea-pig cells by homologous complement.

Authors:  H Okada; H Tanaka; N Okada
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

9.  Murine membrane inhibitor of complement which accelerates decay of human C3 convertase.

Authors:  Y Kameyoshi; M Matsushita; H Okada
Journal:  Immunology       Date:  1989-12       Impact factor: 7.397

10.  Comparative Haploid Genetic Screens Reveal Divergent Pathways in the Biogenesis and Trafficking of Glycophosphatidylinositol-Anchored Proteins.

Authors:  Eric M Davis; Jihye Kim; Bridget L Menasche; Jacob Sheppard; Xuedong Liu; Aik-Choon Tan; Jingshi Shen
Journal:  Cell Rep       Date:  2015-06-11       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.